Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × Vascular Endothelial Growth Factor A × Clear all

NCT00483834 2019-02-15

A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms